Ultragenyx Pharmaceutical Inc. (RARE) — Analyst estimates
Consensus analyst estimates for Ultragenyx Pharmaceutical Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 239.04M | -0.47 | 1 |
| 2027 | 332.91M | 0.62 | 1 |
| 2028 | 1.20B | 0.5 | 12 |
| 2029 | 1.58B | 2.82 | 10 |
| 2030 | 2.12B | 5.33 | 5 |
Consensus analyst estimates by fiscal year.